H.C. Wainwright downgrades Geron on strategy shift, data delay

H.C. Wainwright downgraded Geron (GERN) to Neutral from Buy without a price target following the Q4 report. The shift in guidance for interim data from the IMpactMF study to the second half of 2026 creates a lack of near-term meaningful catalysts, the analyst tells investors in a research note. The firm says Geron is changing its launch strategy after Rytelo’s eight-week and four-week trends showed flat revenues since the holiday season. It cites the delayed data and streategy shift for the downgrade.